SPACTORY, revolutionising pharmaceutical development and manufacturing through microgravity

Introduction

Over 2,000 R&D experiments have been done in Space until now. Space near-zero gravity yields biochemical crystals orders of magnitude more defined, pure, uniform, and precise than in terrestrial environments.

Benefits of Low-Gravity Environments

The low-gravity environment accelerates the development and preclinical testing of complex molecules – e.g. proteins – and unleashes the potential of innovative high-value mAbs therapies, saving patients’ lives and improving their quality of life (QoL).

SPACEPHARMA's Commitment

To make this a reality, after 11 space missions, SPACEPHARMA is committed to bringing the first mAbs factory to Space.

MOTI: The Building Block

MOTI, the main SPACTORY building block, offers:

• Accessible
• Scalable
• Affordable microgravity manufacturing

This system is controlled from Earth and can fly in any satellite compatible with any launcher.

Impact on the Pharma Industry

For our customers in the pharma industry, this means:

1. Shorter time to Space
2. Faster market access
3. Affordable drug development

Paradigm Shift

For SPACEPHARMA, it represents a paradigm shift from drug R&D to manufacturing.

Leading the Spatial Race

For the EU, it means leading the spatial race in drug development.